1 min read

CBD is the Talk of the Town...

It has been making waves in the health sector for quite some time now. However, if you’re new to the world of CBD, you might have come across various types of information on CBD’s legality, manufacturing, packaging, and uses.  Some of it might be authentic, while some of it, not so much.

Norwood Naturals is on a mission to become one of your #1 sources of authentic information on CBD.  Today, we’ll be discussing hemps patent history.  If you’re a curious individual and have done some digging around on the internet, you may have come across information indicating that the U.S. government owns the patent to cannabinoids.

But first, what is a patent?

It's an official document issued by a government through a documented process for exclusive production and sales of an invention. Depending on the type of patent, usually, no one else can ever replicate a patented product’s formula, packaging, or branding without being sued for patent infringement. Patents are granted for a certain period of time and require the applicant to disclose everything about the production process, design, branding, formula, etc.

  • Did the United States Government own the patent?

Yes, it is true. 

The United States Government, through the Department of Health and Human Services, applied for and secured a patent for non-intoxicating and non-psychoactive Cannabinoids for treatment purposes, (which includes CBD).  The patent was approved on October 7, 2003. Patent Number #06630507.  The patent was titled “Cannabinoids as Antioxidants and Neuroprotectants”

  • Who received the patent after the United States Government? 

On July 2, 2019.  The new owner of the incredible plant patent filled with hundreds of medicinal properties is Mr. Joel Stanley founder and first CEO of Charlotte’s Web. The name of the new patent is the "Hemp Cultivar."
The patent protects against any competitor growing the same cultivar as CWB Holdings from a clone. Owning the Hemp patent will definitely allow them to command a huge chunk of the cannabinoid market share.


* The email will not be published on the website.